Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Filings indexed 698 across all filing types
Latest filing 2026-03-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and contractual relationships (pledges, loans, sales agreements) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-03-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or on-market purchase) by an executive (Kim Jae-gyo) of Hanmi Science. This is a standard regulatory filing for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2026-02-27 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) for Hanmi Science. It details specific share transactions (purchases) by company executives and major shareholders, including the date of change, the number of shares, and the updated total ownership. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders and major shareholders.
2026-02-27 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 95% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This is a regulatory filing required by South Korean law for insiders planning to trade company shares. Since it details specific trading plans by an insider (Shin Dong Guk) and does not fit into the other specific categories like 'Director's Dealing' (which usually reports completed trades) or 'Major Shareholding Notification' (which reports threshold crossings), it is classified as a Regulatory Filing (RNS).
2026-02-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including specific share purchase agreements and collateral arrangements. According to the provided filing definitions, this type of document, which reports significant changes in share ownership levels, is classified as a Major Shareholding Notification (MRQ).
2026-02-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and contractual agreements (such as stock purchase agreements and collateral agreements) of major shareholders. This fits the definition of a Major Shareholding Notification (MRQ).
2026-02-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.